Purchase Order #75N98026P00517

PSOMAGEN Contract for Proteomic Analysis in Sepsis Biomarker Study

This award is a purchase order contract granted to PSOMAGEN Inc., a company specializing in advanced genomic and proteomic services. The contract involves conducting Olink Explore High-Throughput Proteomic Analysis to support a significant sepsis biomarker study led by the National Heart, Lung, and Blood Institute (NHLBI). The primary goal is to identify critical biological markers for sepsis diagnosis or treatment, contributing valuable insights to biomedical research focused on this serious condition. The scope includes performing precise, high-throughput proteomic analysis using specialized Olink Explore technology. Awarded through a competitive purchase order process, this contract allows for a streamlined acquisition of specialized scientific services. The performance period is a concise term of about six months, starting in mid-May and concluding in late November of 2026, with work conducted in Rockville, Maryland. No subcontractors or related previous contracts were indicated, and this engagement represents an important, focused investment in advancing sepsis research through cutting-edge proteomic techniques.

Description

NHLBI: SERVICE: OLINK EXPLORE HT PROTEOMIC ANALYSIS FOR SEPSIS BIOMARKER STUDY: SEVERABLE

View original record